Literature DB >> 17942770

Cocaine use and hypertensive renal changes in HIV-infected individuals.

Derek M Fine1, Neha Garg, Mark Haas, M Hafizur Rahman, Gregory M Lucas, Paul J Scheel, Mohamed G Atta.   

Abstract

BACKGROUND AND OBJECTIVES: Cocaine causes kidney damage, but data linking cocaine use to chronic kidney disease in HIV patients is not described. This study was conducted to evaluate the possible association of cocaine use and histopathologic findings on biopsy in this population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Kidney biopsies that were performed in HIV-infected patients during the course of 11 yr were reviewed. Demographic and clinical data were collected. Hypertensive changes were defined on the basis of the Banff 97 classification. Criteria of both arterial intimal fibrosis and thickening and hyaline arteriolosclerosis were used and graded as absent (0), mild (1), moderate (2), and severe (3). Hypertensive renal changes were considered present when the combined pathology score was > or = 2. To minimize confounding, those with hypertension or diabetes were excluded.
RESULTS: Of the 193 HIV patients who underwent kidney biopsy, 53 had no history of hypertension or diabetes with HIV infection. Of those, 29 (55%) had hypertensive renal changes on kidney biopsy. Cocaine use was present in 16 (55%) of 29 with hypertensive renal changes compared with six (25%) of 24 without hypertensive renal changes (odds ratio [OR] 3.7; 95% confidence interval [CI] 1.2 to 11.7). In the adjusted analyses, only age (/yr; OR 1.08; 95% CI 1.00 to 1.16) and cocaine use (OR 3.55; 95% CI 1.04 to 12.14) were significantly associated with hypertensive renal changes on renal biopsy.
CONCLUSIONS: Cocaine use is associated with hypertensive renal changes in HIV-infected patients in the absence of hypertension and diabetes.

Entities:  

Mesh:

Year:  2007        PMID: 17942770     DOI: 10.2215/CJN.02450607

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  13 in total

1.  The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Authors:  Michelle M Estrella; Rulan S Parekh; Alison Abraham; Brad C Astor; Lynda A Szczech; Kathryn Anastos; Jack A Dehovitz; Daniel J Merenstein; C Leigh Pearce; Phyllis C Tien; Mardge H Cohen; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

2.  Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Authors:  Gregory M Lucas; Yuezhou Jing; Mark Sulkowski; Alison G Abraham; Michelle M Estrella; Mohamed G Atta; Derek M Fine; Marina B Klein; Michael J Silverberg; M John Gill; Richard D Moore; Kelly A Gebo; Timothy R Sterling; Adeel A Butt
Journal:  J Infect Dis       Date:  2013-07-31       Impact factor: 5.226

3.  HIV and proteinuria in an injection drug user population.

Authors:  Elizabeth L Yanik; Gregory M Lucas; David Vlahov; Gregory D Kirk; Shruti H Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-12       Impact factor: 8.237

4.  Recent developments in HIV-related kidney disease.

Authors:  Michelle M Estrella; Derek M Fine; Mohamed G Atta
Journal:  HIV Ther       Date:  2010-09

5.  Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.

Authors:  Shikha Garg; Melanie Hoenig; Erika M Edwards; Caleb Bliss; Timothy Heeren; Sheila Tumilty; Alexander Y Walley; Margaret J Koziel; Paul R Skolnik; C Robert Horsburgh; Deborah Cotton
Journal:  AIDS Patient Care STDS       Date:  2011-02-10       Impact factor: 5.078

Review 6.  Screening for chronic kidney disease in HIV-infected patients.

Authors:  Michelle M Estrella; Derek M Fine
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

Review 7.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease.

Authors:  Gregory M Lucas; Mohamed G Atta; Derek M Fine; Allison M McFall; Michelle M Estrella; Katie Zook; James H Stein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-08       Impact factor: 8.311

9.  Risk behaviors among HIV-positive gay and bisexual men at party-oriented vacations.

Authors:  Michael P Fisher; Rajeev Ramchand; Sarah Bana; Martin Y Iguchi
Journal:  J Stud Alcohol Drugs       Date:  2013-01       Impact factor: 2.582

10.  Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.

Authors:  Gregory M Lucas; Mohamed G Atta; Katie Zook; Allison M McFall; Shruti H Mehta; Derek M Fine; James H Stein; George J Schwartz
Journal:  AIDS       Date:  2016-02-20       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.